echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > Eur Urol Oncol: Comparison of the detection of clinically significant prostate cancer with a four-core targeted biopsy versus a nine-core targeted saturation biopsy for transperineal prostate fusion biopsy

    Eur Urol Oncol: Comparison of the detection of clinically significant prostate cancer with a four-core targeted biopsy versus a nine-core targeted saturation biopsy for transperineal prostate fusion biopsy

    • Last Update: 2022-10-12
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Multiparametric magnetic resonance imaging (mpMRI) and targeted biopsy (TB) help accurately detect clinically significant prostate cancer (csPC


    Recently, researchers from Germany published an article in Eur Urol Oncol evaluating the csPC detection rate of two targeted MRI/transrectal ultrasonography (TRUS) fusion biopsy methods, namely conventional TB and targeted saturation biopsy (TS).


    The study was a prospective single-center design in which 170 men were biopsy


    The researchers used the McNemar test to analyze PC and csPC (International Society of Urological Pathology Grade ≥2) detection rates for systemic biopsy (SB), TB, and TS, and compared


    The results of the study showed that 57 men in the TS group were diagnosed with csPC and 36 men in the TB group were diagnosed with csPC


    Comparison of detection rates for different methods

    In summary, there was no significant difference


    Original Source:

    Yasemin Melisa Saner , Manuel Wiesenfarth , Vivienn Weru et al.


     

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.